Alterations of systemic endotoxemia over the course of acute edematous pancreatitis. correlation to the advent of an infection?

Meta-analysis of gut barrier dysfunction in patients with acute pancreatitis

BACKGROUND

The gut is implicated in the pathogenesis of acute pancreatitis but there is discrepancy between individual studies regarding the prevalence of gut barrier dysfunction in patients with acute pancreatitis. The aim of this study was to determine the prevalence of gut barrier dysfunction in acute pancreatitis, the effect of different co-variables, and changes in gut barrier function associated with the use of various therapeutic modalities.

METHODS

A literature search was performed using PRISMA and MOOSE guidelines. Summary estimates were presented as pooled prevalence of gut barrier dysfunction and the associated 95 per cent c.i.

RESULTS

A total of 44 prospective clinical studies were included in the systematic review, of which 18 studies were subjected to meta-analysis. The pooled prevalence of gut barrier dysfunction was 59 (95 per cent c.i. 48 to 70) per cent; the prevalence was not significantly affected by disease severity, timing of assessment after hospital admission or type of test used, but showed a statistically significant association with age. Overall, nine of 13 randomized clinical trials reported a significant improvement in gut barrier function following intervention compared with the control group, but only three of six studies that used standard enteral nutrition reported a statistically significant improvement in gut barrier function after intervention.

CONCLUSION

Gut barrier dysfunction is present in three of five patients with acute pancreatitis, and the prevalence is affected by patient age but not by disease severity. Clinical studies are needed to evaluate the effect of enteral nutrition on gut function in acute pancreatitis.

Risk factors and nursing strategies for severe acute pancreatitis complicated with multiple organ dysfunction syndrome

AIM: To explore the risk factors and nursing strategies for severe acute pancreatitis (SAP) complicated with multiple organ dysfunction syndrome (MODS).

METHODS: Clinical data for 134 patients with SAP were retrospectively analyzed. Based on the presence of MODS or not, the patients were divided into two groups, those complicated with or without MODS. Risk factors and nursing strategies for SAP with MODS were then analyzed.

RESULTS: Logistic regression analysis demonstrated that shock, biliary obstruction, hyperlipidemia, hypoxemia, lung infection, pleural effusion, abdominal cavity room partition syndrome and Ranson's score, APACHE II score, and CT score were independent risk factors for SAP complicated with MODS (OR = 1.193, 1.016, 1.004, 1.193, 1.049, 1.055, 1.081, 1.100, 1.027, all P < 0.05). Nursing for SAP with MODS should focus on monitoring the patient's vital signs and strengthening the management of respiratory function, renal function, blood coagulation function and intestinal function.

CONCLUSION: Awareness of risk factors for SAP complicated with MODS should be raised to conduct active intervention to improve prognosis. Optimization of nursing management of SAP complicated with MODS can help reduce mortality.

Bacterial translocation in an experimental model of multiple organ dysfunctions

BACKGROUND

In order to investigate the hypothesis that bacterial translocation from the intestine contributes to death after multiple organ dysfunction syndrome (MODS), a sterile MODS model was studied.

METHODS

MODS was induced in 139 male C57BL/6 mice by lipopolysaccharide (LPS) (endotoxin) infusion followed by zymozan infusion in four groups: Α, sham-operation; Β, LPS; C, LPS + 0.8 g/kg zymozan; and D, LPS + 1.2 g/kg zymozan. Mice were sacrificed at 24 and 48 h for quantitative tissue cultures, isolation, and stimulation of splenocytes, measurement of apoptosis of lymphocytes and macrophages, and of serum LPS and survival. Some mice with MODS were treated with the antibiotic ertapenem.

RESULTS

Enterobacteriaceae and Enterococcus spp were isolated from tissues. Group D had the highest bacterial load and the shortest survival. Release of interleukin-10, of interleukin-17, and of intgerferon-γ by splenocytes and the rate of apoptosis did not concur with immune paralysis. Serum LPS concentrations were higher in mice with MODS versus controls. Ertapenem prolonged survival and decreased the bacterial load.

CONCLUSIONS

Bacterial translocation seems to be an important contributor leading from MODS to death and suggests a change in therapy towards adaptation of antimicrobial treatment upon early signs of MODS.

Changes in adaptive and innate immunity in patients with acute pancreatitis and systemic inflammatory response syndrome

BACKGROUND

Acute pancreatitis is a form of inflammation with clinical features ranging from pancreatic inflammation to fatal systemic manifestations. The aim of this study was to clarify changes in lymphocyte subsets and alterations in the functioning of natural killer (NK) cells.

PATIENTS AND METHODS

Forty-five patients were enrolled into the study; 35 with acute pancreatitis and systemic inflammatory response syndrome (SIRS) and 10 healthy subjects. Blood was sampled early from all patients. Blood immune cells were studied on days 1 and 4 by flow cytometry. Tumor necrosis factor-α (TNFα) and interleukin (IL)-6 were estimated from supernatants of NK cells before/after stimulation with lipopolysaccharide (LPS).

RESULTS

Apoptosis in patients was significantly different on days 1 and 4 compared with controls. Apoptosis of CD4(+) lymphocytes was significantly correlated with the days to resolution of SIRS (r = +0.586, p = 0.022). Significant differences were observed in TNFα and IL-6 on day 1 with/without LPS stimulation between patients and healthy individuals. Significantly increased levels of TNFα and IL-6 were found after LPS stimulation compared with unstimulated supernatants in day 1.

CONCLUSION

NK cells altered their secretory status when stimulated with LPS. This finding could be explained by the cellular reprogramming of NK cells in the field of acute pancreatitis and SIRS.

Changes of endotoximia, cytokines and nitric oxide and therapeutic effects of sandostatin in rats with severe acute pancreatitis

AIM: To study the roles of endotoximia, cytokines and nitric oxide in the development of severe acute pancreatitis (SAP) and the therapeutic effects of sandostatin (SS) in rats.

METHODS: SAP models were induced by retrograde injection of 15 g/L sodium deoxycholate and then treated by SS. The plasma levels of endotoxin (ET), lipid peroxide (LPO), tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6) and nitric oxide (NO), as well as the expression LPO, TNF-α, IL-6 and NO in pancreatic tissues, were measured. The changes of pancreatic histology were examined under light microscope.

RESULTS: As Compared with those in sham operation group, the plasma levels of ET, LPO, TNF-α, IL-6 and NO were markedly higher in SAP group (P < 0.01), and the changes of ET, LPO, TNF-α and NO at 6 h were higher (898 ± 114 EU/L, 24.58 ± 1.23 μmol/L, 246.3 ± 16.5 ng/L, 162.8 ± 10.9 mmol/L, P < 0.05) than those at 12 and 24 h. The changes of LPO, TNF-α, IL-6 and NO in pancreatic tissues of SAP group were obviously higher in comparison with those of sham group (3.31 ± 0.85 μmol/g vs0.33 ± 0.04 μmol/g, P < 0.01; 2.57 ± 0.14 ng/g vs 0.16 ± 0.04 ng/g, P < 0.01; 85.6 ± 24.6 ng/g vs 32.5 ± 5.7 ng/g, P < 0.01; 15.3 ± 1.2 mmol/g vs 6.6 ± 1.4 mmol/g, P < 0.01); and severe damages of pancreatic tissues were observed under light microscope. In SAP group, the plasma levels of LPO, TNF-α, IL-6 and NO were significantly correlated with ET level (r = 0.858,P < 0.01; r = 0.958, P < 0.01; r = 0.918, P < 0.01; r = 0.875, P < 0.01). The indexes mentioned above in SS group were obviously ameliorated in comparison with those in SAP group (P < 0.01).

CONCLUSION: Endotoximia, cytokines and NO play important roles in the development of severe acute pancreatitis. Sandostatin can block the chain reaction caused by these factors.

Mesenteric lymph duct ligation decreases red blood cell alterations caused by acute pancreatitis

BACKGROUND

Both experimental and clinical studies have shown that acute pancreatitis (AP) causes a significant decrease in red blood cell (RBC) deformability. The mechanisms by which AP induces RBC injury are unknown. The purpose of this study was to test the hypothesis that factors carried in the mesenteric lymph after an attack of AP significantly contribute to the RBC injury observed in AP.

METHODS

RBC deformability was determined by means of laser-assisted ektacytometry in mesenteric lymph duct-ligated and non-ligated rats subjected to AP and in sham-operated animals.

RESULTS

AP was associated with significant alterations of RBC deformability indices, namely the elongation index and half maximal RBC elongation. Pancreatitis-induced RBC deformability changes were partially prevented by mesenteric lymph duct ligation.

CONCLUSIONS

Mesenteric lymph in AP contains factors that cause RBC damage, which is manifested by decreased deformability. Interruption of the lymph flow from the injured gut into the bloodstream decreases these RBC alterations.

The isolated perfused liver response to a 'second hit' of portal endotoxin during severe acute pancreatitis

BACKGROUND/AIM

During severe acute pancreatitis (AP), the liver may show an exaggerated response to the inflammatory products of gut injury transported in the portal vein. Our aim was to explore liver proinflammatory mediator production after a 'second hit' of portal lipopolysaccharide (LPS) during AP.

METHODS

Twenty-four rats underwent one of three 'first-hit' scenarios: (1) severe AP induced by intraductal glycodeoxycholic acid injection and intravenous caerulein infusion, (2) sham laparotomy, or (3) no first intervention. Eighteen hours later, all animals received a 'second hit' of portal LPS in an isolated liver perfusion system. Tumour necrosis factor-alpha (TNF-alpha), interleukin (IL)-1beta, and IL-6 concentrations were measured in portal and systemic serum, and in the perfusate 30 and 90 min after the 'second hit'. Neutrophil activation by the perfusate was assayed using dihydrorhodamine-123 fluorescence.

RESULTS

We observed a six-fold increase in IL-6 concentration across the liver during AP. All livers produced TNF-alpha after the portal LPS challenge, but this was not exaggerated by AP. No differential neutrophil activation by the perfusate was seen.

CONCLUSION

TNF-alpha, IL-1beta, IL-6 and neutrophil activator production by the isolated perfused liver, in response to a 'second hit' of portal LPS, does not appear to be enhanced during AP.